Trial Profile
Randomized, Double-blind, Placebo-controlled, Dose-escalation, Repeated and Single Oral Dosing Phase I Study to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Temanogrel Co-administered With Aspirin and Clopidogrel
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Temanogrel (Primary) ; Aspirin; Clopidogrel
- Indications Acute coronary syndromes
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Ildong Pharmaceutical
- 11 Feb 2019 Status changed to discontinued.
- 17 Jun 2018 Status changed from recruiting to completed.
- 22 Apr 2015 New trial record